Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer (Q38840480)

6 September 2017

Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer (English)

1 reference

6 September 2017

0 references

1 reference

10

1 reference

6 September 2017

Karim Fahmy

1

1 reference

6 September 2017

Arnaud Gonzalez

2

1 reference

6 September 2017

Mohammad Arafa

3

1 reference

6 September 2017

Paul Peixoto

4

1 reference

6 September 2017

Akeila Bellahcène

5

1 reference

6 September 2017

Andrei Turtoi

6

1 reference

6 September 2017

Philippe Delvenne

7

1 reference

6 September 2017

Marc Thiry

8

1 reference

6 September 2017

Vincent Castronovo

9

1 reference

6 September 2017

language of work or name

English

0 references

publication date

27 August 2015

1 reference

International Journal of Cancer

6 September 2017

1 reference

6 September 2017

138

1 reference

6 September 2017

3

1 reference

6 September 2017

652-663

1 reference

The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion.

6 September 2017

1 reference

Molecular bandages: inside-out, outside-in repair of cellular membranes. Focus on "Myoferlin is critical for endocytosis in endothelial cells".

21 January 2018

1 reference

Myoferlin is critical for endocytosis in endothelial cells

21 January 2018

1 reference

Myoferlin regulates vascular endothelial growth factor receptor-2 stability and function

21 January 2018

1 reference

Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair

21 January 2018

1 reference

Expression of myoferlin in human and murine carcinoma tumors: role in membrane repair, cell proliferation, and tumorigenesis

21 January 2018

1 reference

Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications

21 January 2018

1 reference

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

21 January 2018

1 reference

iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma

21 January 2018

1 reference

Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.

21 January 2018

1 reference

Mechanistic modeling of the effects of myoferlin on tumor cell invasion

21 January 2018

1 reference

Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion

21 January 2018

1 reference

Loss of myoferlin redirects breast cancer cell motility towards collective migration

21 January 2018

1 reference

Myoferlin is a key regulator of EGFR activity in breast cancer

21 January 2018

1 reference

The anti-tumor effect of HDAC inhibition in a human pancreas cancer model is significantly improved by the simultaneous inhibition of cyclooxygenase 2

21 January 2018

1 reference

HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells.

21 January 2018

1 reference

A guided tour into subcellular colocalization analysis in light microscopy

21 January 2018

1 reference

High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade

21 January 2018

1 reference

A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws.

21 January 2018

1 reference

A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma

21 January 2018

1 reference

SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis

21 January 2018

1 reference

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

21 January 2018

1 reference

Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo

21 January 2018

1 reference

The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers

21 January 2018

1 reference

Biology of angiogenesis in tumors of the gastrointestinal tract

21 January 2018

1 reference

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

21 January 2018

1 reference

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

Normal myoblast fusion requires myoferlin

21 January 2018

1 reference

Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse

21 January 2018

1 reference

Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains

21 January 2018

1 reference

Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair.

21 January 2018

1 reference

Role of synaptotagmin in Ca2+-triggered exocytosis

21 January 2018

1 reference

Prognostic significance of angiogenesis in human pancreatic cancer

21 January 2018

1 reference

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

VEGFA gene locus analysis across 80 human tumour types reveals gene amplification in several neoplastic entities

21 January 2018

1 reference

VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA.

21 January 2018

1 reference

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

21 January 2018

1 reference

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study

21 January 2018

1 reference

Myoferlin is required for insulin-like growth factor response and muscle growth

21 January 2018

1 reference

Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.

21 January 2018

1 reference

Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29820

1 reference

6 September 2017

1 reference